Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1

William Hankey, Zhong Chen, Maxwell J. Bergman, Max O. Fernandez, Baris Hancioglu, Xun Lan, Anil G. Jegga, Jie Zhang, Victor X. Jin, Bruce J. Aronow, Qianben Wang, Joanna Groden

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mutation of the APC gene occurs in a high percentage of colorectal tumors and is a central event driving tumor initiation in the large intestine. The APC protein performs multiple tumor suppressor functions including negative regulation of the canonical WNT signaling pathway by both cytoplasmic and nuclear mechanisms. Published reports that APC interacts with ß-catenin in the chromatin fraction to repress WNT-activated targets have raised the possibility that chromatin-associated APC participates more broadly in mechanisms of transcriptional control. This screening study has used chromatin immunoprecipitation and next-generation sequencing to identify APC-associated genomic regions in colon cancer cell lines. Initial target selection was performed by comparison and statistical analysis of 3,985 genomic regions associated with the APC protein to whole transcriptome sequencing data from APC-deficient and APC-wild-type colon cancer cells, and two types of murine colon adenomas characterized by activated Wnt signaling. 289 transcripts altered in expression following APC loss in human cells were linked to APC-associated genomic regions. High-confidence targets additionally validated in mouse adenomas included 16 increased and 9 decreased in expression following APC loss, indicating that chromatin-associated APC may antagonize canonical WNT signaling at both WNT-activated and WNT-repressed targets. Motif analysis and comparison to ChIP-seq datasets for other transcription factors identified a prevalence of binding sites for the TCF7L2 and AP-1 transcription factors in APCassociated genomic regions. Our results indicate that canonical WNT signaling can collaborate with or antagonize the AP-1 transcription factor to fine-tune the expression of shared target genes in the colorectal epithelium. Future therapeutic strategies for APC-deficient colorectal cancers might be expanded to include agents targeting the AP-1 pathway.

Original languageEnglish (US)
Pages (from-to)31214-31230
Number of pages17
JournalOncotarget
Volume9
Issue number58
DOIs
StatePublished - Jul 27 2018

Fingerprint

APC Genes
Transcription Factor AP-1
Chromatin
Gene Expression
Adenoma
Colonic Neoplasms
Colorectal Neoplasms
Catenins
Chromatin Immunoprecipitation
Large Intestine
Transcriptome
Neoplasms
Colon
Proteins
Transcription Factors
Epithelium
Binding Sites
Cell Line
Mutation
Genes

Keywords

  • AP-1
  • APC
  • Canonical WNT signaling
  • Chromatin
  • Colorectal cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Hankey, W., Chen, Z., Bergman, M. J., Fernandez, M. O., Hancioglu, B., Lan, X., ... Groden, J. (2018). Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. Oncotarget, 9(58), 31214-31230. https://doi.org/10.18632/oncotarget.25781

Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. / Hankey, William; Chen, Zhong; Bergman, Maxwell J.; Fernandez, Max O.; Hancioglu, Baris; Lan, Xun; Jegga, Anil G.; Zhang, Jie; Jin, Victor X.; Aronow, Bruce J.; Wang, Qianben; Groden, Joanna.

In: Oncotarget, Vol. 9, No. 58, 27.07.2018, p. 31214-31230.

Research output: Contribution to journalArticle

Hankey, W, Chen, Z, Bergman, MJ, Fernandez, MO, Hancioglu, B, Lan, X, Jegga, AG, Zhang, J, Jin, VX, Aronow, BJ, Wang, Q & Groden, J 2018, 'Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1', Oncotarget, vol. 9, no. 58, pp. 31214-31230. https://doi.org/10.18632/oncotarget.25781
Hankey W, Chen Z, Bergman MJ, Fernandez MO, Hancioglu B, Lan X et al. Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. Oncotarget. 2018 Jul 27;9(58):31214-31230. https://doi.org/10.18632/oncotarget.25781
Hankey, William ; Chen, Zhong ; Bergman, Maxwell J. ; Fernandez, Max O. ; Hancioglu, Baris ; Lan, Xun ; Jegga, Anil G. ; Zhang, Jie ; Jin, Victor X. ; Aronow, Bruce J. ; Wang, Qianben ; Groden, Joanna. / Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. In: Oncotarget. 2018 ; Vol. 9, No. 58. pp. 31214-31230.
@article{cca4dc456b4e44a0ac207c2f4c44e4ca,
title = "Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1",
abstract = "Mutation of the APC gene occurs in a high percentage of colorectal tumors and is a central event driving tumor initiation in the large intestine. The APC protein performs multiple tumor suppressor functions including negative regulation of the canonical WNT signaling pathway by both cytoplasmic and nuclear mechanisms. Published reports that APC interacts with {\ss}-catenin in the chromatin fraction to repress WNT-activated targets have raised the possibility that chromatin-associated APC participates more broadly in mechanisms of transcriptional control. This screening study has used chromatin immunoprecipitation and next-generation sequencing to identify APC-associated genomic regions in colon cancer cell lines. Initial target selection was performed by comparison and statistical analysis of 3,985 genomic regions associated with the APC protein to whole transcriptome sequencing data from APC-deficient and APC-wild-type colon cancer cells, and two types of murine colon adenomas characterized by activated Wnt signaling. 289 transcripts altered in expression following APC loss in human cells were linked to APC-associated genomic regions. High-confidence targets additionally validated in mouse adenomas included 16 increased and 9 decreased in expression following APC loss, indicating that chromatin-associated APC may antagonize canonical WNT signaling at both WNT-activated and WNT-repressed targets. Motif analysis and comparison to ChIP-seq datasets for other transcription factors identified a prevalence of binding sites for the TCF7L2 and AP-1 transcription factors in APCassociated genomic regions. Our results indicate that canonical WNT signaling can collaborate with or antagonize the AP-1 transcription factor to fine-tune the expression of shared target genes in the colorectal epithelium. Future therapeutic strategies for APC-deficient colorectal cancers might be expanded to include agents targeting the AP-1 pathway.",
keywords = "AP-1, APC, Canonical WNT signaling, Chromatin, Colorectal cancer",
author = "William Hankey and Zhong Chen and Bergman, {Maxwell J.} and Fernandez, {Max O.} and Baris Hancioglu and Xun Lan and Jegga, {Anil G.} and Jie Zhang and Jin, {Victor X.} and Aronow, {Bruce J.} and Qianben Wang and Joanna Groden",
year = "2018",
month = "7",
day = "27",
doi = "10.18632/oncotarget.25781",
language = "English (US)",
volume = "9",
pages = "31214--31230",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "58",

}

TY - JOUR

T1 - Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1

AU - Hankey, William

AU - Chen, Zhong

AU - Bergman, Maxwell J.

AU - Fernandez, Max O.

AU - Hancioglu, Baris

AU - Lan, Xun

AU - Jegga, Anil G.

AU - Zhang, Jie

AU - Jin, Victor X.

AU - Aronow, Bruce J.

AU - Wang, Qianben

AU - Groden, Joanna

PY - 2018/7/27

Y1 - 2018/7/27

N2 - Mutation of the APC gene occurs in a high percentage of colorectal tumors and is a central event driving tumor initiation in the large intestine. The APC protein performs multiple tumor suppressor functions including negative regulation of the canonical WNT signaling pathway by both cytoplasmic and nuclear mechanisms. Published reports that APC interacts with ß-catenin in the chromatin fraction to repress WNT-activated targets have raised the possibility that chromatin-associated APC participates more broadly in mechanisms of transcriptional control. This screening study has used chromatin immunoprecipitation and next-generation sequencing to identify APC-associated genomic regions in colon cancer cell lines. Initial target selection was performed by comparison and statistical analysis of 3,985 genomic regions associated with the APC protein to whole transcriptome sequencing data from APC-deficient and APC-wild-type colon cancer cells, and two types of murine colon adenomas characterized by activated Wnt signaling. 289 transcripts altered in expression following APC loss in human cells were linked to APC-associated genomic regions. High-confidence targets additionally validated in mouse adenomas included 16 increased and 9 decreased in expression following APC loss, indicating that chromatin-associated APC may antagonize canonical WNT signaling at both WNT-activated and WNT-repressed targets. Motif analysis and comparison to ChIP-seq datasets for other transcription factors identified a prevalence of binding sites for the TCF7L2 and AP-1 transcription factors in APCassociated genomic regions. Our results indicate that canonical WNT signaling can collaborate with or antagonize the AP-1 transcription factor to fine-tune the expression of shared target genes in the colorectal epithelium. Future therapeutic strategies for APC-deficient colorectal cancers might be expanded to include agents targeting the AP-1 pathway.

AB - Mutation of the APC gene occurs in a high percentage of colorectal tumors and is a central event driving tumor initiation in the large intestine. The APC protein performs multiple tumor suppressor functions including negative regulation of the canonical WNT signaling pathway by both cytoplasmic and nuclear mechanisms. Published reports that APC interacts with ß-catenin in the chromatin fraction to repress WNT-activated targets have raised the possibility that chromatin-associated APC participates more broadly in mechanisms of transcriptional control. This screening study has used chromatin immunoprecipitation and next-generation sequencing to identify APC-associated genomic regions in colon cancer cell lines. Initial target selection was performed by comparison and statistical analysis of 3,985 genomic regions associated with the APC protein to whole transcriptome sequencing data from APC-deficient and APC-wild-type colon cancer cells, and two types of murine colon adenomas characterized by activated Wnt signaling. 289 transcripts altered in expression following APC loss in human cells were linked to APC-associated genomic regions. High-confidence targets additionally validated in mouse adenomas included 16 increased and 9 decreased in expression following APC loss, indicating that chromatin-associated APC may antagonize canonical WNT signaling at both WNT-activated and WNT-repressed targets. Motif analysis and comparison to ChIP-seq datasets for other transcription factors identified a prevalence of binding sites for the TCF7L2 and AP-1 transcription factors in APCassociated genomic regions. Our results indicate that canonical WNT signaling can collaborate with or antagonize the AP-1 transcription factor to fine-tune the expression of shared target genes in the colorectal epithelium. Future therapeutic strategies for APC-deficient colorectal cancers might be expanded to include agents targeting the AP-1 pathway.

KW - AP-1

KW - APC

KW - Canonical WNT signaling

KW - Chromatin

KW - Colorectal cancer

UR - http://www.scopus.com/inward/record.url?scp=85050699142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050699142&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.25781

DO - 10.18632/oncotarget.25781

M3 - Article

AN - SCOPUS:85050699142

VL - 9

SP - 31214

EP - 31230

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 58

ER -